Clinical Trial Update: Tetrabenazine for Partial Responders [NA]

View source ↗

Summary

A completed clinical trial evaluated tetrabenazine as a treatment option for partial responders with schizophrenia or schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Xenazine (tetrabenazine)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED